Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Analysis and natural history of pituitary incidentalomas.

Imran SA, Yip CE, Papneja N, Aldahmani K, Mohammad S, Imran F, Zwicker DA, Theriault C, Thompson K, Clarke DB, Van Uum S.

Eur J Endocrinol. 2016 Jul;175(1):1-9. doi: 10.1530/EJE-16-0041. Epub 2016 Apr 1.

PMID:
27037179
2.

Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism.

Munro V, Tugwell B, Doucette S, Clarke DB, Lacroix A, Imran SA.

Clin Endocrinol (Oxf). 2016 Aug;85(2):216-22. doi: 10.1111/cen.13048. Epub 2016 Mar 21.

PMID:
26928716
3.

Thyroid hormone (levothyroxine) replacement via the respiratory route by inhalation: in vitro exploratory studies.

Agu RU, Mactavish J, K Yeung P, Imran SA.

Expert Opin Drug Deliv. 2016 Feb;13(2):195-205. doi: 10.1517/17425247.2016.1115012. Epub 2015 Dec 18.

PMID:
26684066
4.

Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.

Imran SA, Tiemensma J, Kaiser SM, Vallis M, Doucette S, Abidi E, Yip CE, De Tugwell B, Siddiqi F, Clarke DB.

Eur J Endocrinol. 2016 Jan;174(1):41-50. doi: 10.1530/EJE-15-0888.

PMID:
26586838
5.

Sellar Masses: An Epidemiological Study.

Al-Dahmani K, Mohammad S, Imran F, Theriault C, Doucette S, Zwicker D, Yip CE, Clarke DB, Imran SA.

Can J Neurol Sci. 2016 Mar;43(2):291-7. doi: 10.1017/cjn.2015.301. Epub 2015 Nov 2.

PMID:
26522017
6.

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.

Schopohl J, Gu F, Rubens R, Van Gaal L, Bertherat J, Ligueros-Saylan M, Trovato A, Hughes G, Salgado LR, Boscaro M, Pivonello R; Pasireotide B2305 Study Group.

Pituitary. 2015 Oct;18(5):604-12. doi: 10.1007/s11102-014-0618-1.

7.

D-WISE: Diabetes Web-Centric Information and Support Environment: conceptual specification and proposed evaluation.

Abidi S, Vallis M, Raza Abidi SS, Piccinini-Vallis H, Imran SA.

Can J Diabetes. 2014 Jun;38(3):205-11. doi: 10.1016/j.jcjd.2014.03.006.

8.

Diabetes in primary care: back to basics.

Imran SA, Tugwell B, Harris S.

Can J Diabetes. 2014 Jun;38(3):155-6. doi: 10.1016/j.jcjd.2014.03.011. No abstract available.

PMID:
24909084
9.

Presentation of atrial fibrillation following oral dexamethasone treatment in a NF2 patient.

Hebb AL, Imran SA, Morris DP, Bance M, Walling S.

Am J Otolaryngol. 2014 Sep-Oct;35(5):678-82. doi: 10.1016/j.amjoto.2014.04.006. Epub 2014 May 2.

PMID:
24888793
10.

Targets for glycemic control.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Imran SA, Rabasa-Lhoret R, Ross S.

Can J Diabetes. 2013 Apr;37 Suppl 1:S31-4. doi: 10.1016/j.jcjd.2013.01.016. Epub 2013 Mar 26. No abstract available.

PMID:
24070959
11.

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.

Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM; Pasireotide B2305 Study Group.

Clin Endocrinol (Oxf). 2014 Sep;81(3):408-17. doi: 10.1111/cen.12431. Epub 2014 Mar 27.

PMID:
24533697
12.

Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? A study in two Canadian centers.

Siu S, McDonald JT, Rajaraman M, Franklin J, Paul T, Rachinsky I, Morrison D, Imran SA, Burrell S, Hart R, Driedger A, Badreddine M, Yoo J, Corsten M, Van Uum S.

Thyroid. 2014 Mar;24(3):545-51. doi: 10.1089/thy.2013.0090. Epub 2013 Dec 13.

PMID:
24020873
13.

The role of morning basal serum cortisol in assessment of hypothalamic pituitary-adrenal axis.

Yip CE, Stewart SA, Imran F, Clarke DB, Mokashi A, Kaiser SM, Imran SA.

Clin Invest Med. 2013 Aug 1;36(4):E216-22.

PMID:
23906493
14.

Emerging trends in the diagnosis and treatment of acromegaly in Canada.

Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Van Uum S, Rivera J, Caspar-Bell G, Serri O.

Clin Endocrinol (Oxf). 2013 Jul;79(1):79-85. doi: 10.1111/cen.12112. Epub 2013 Apr 27.

PMID:
23190441
15.

Superinduction of leptin mRNA in mouse hypothalamic neurons.

Brown RE, Wilkinson DA, Wilkinson PM, Imran SA, Wilkinson M.

Neuroreport. 2012 Oct 24;23(15):900-3. doi: 10.1097/WNR.0b013e3283595709.

PMID:
22964970
16.

KISS1 expression in human female adipose tissue.

Cockwell H, Wilkinson DA, Bouzayen R, Imran SA, Brown R, Wilkinson M.

Arch Gynecol Obstet. 2013 Jan;287(1):143-7. doi: 10.1007/s00404-012-2514-0. Epub 2012 Aug 17.

PMID:
22899305
17.

Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer.

Abonowara A, Quraishi A, Sapp JL, Alqambar MH, Saric A, O'Connell CM, Rajaraman MM, Hart RD, Imran SA.

Clin Invest Med. 2012 Jun 1;35(3):E152-6.

PMID:
22673318
18.

Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).

Brown RE, Wilkinson DA, Imran SA, Caraty A, Wilkinson M.

Brain Res. 2012 Jul 27;1467:1-9. doi: 10.1016/j.brainres.2012.05.049. Epub 2012 Jun 2.

PMID:
22668987
19.

Management of prolactinomas during pregnancy -- a survey of four Canadian provinces.

Almalki MH, Ur E, Johnson M, Clarke DB, Imran SA.

Clin Invest Med. 2012 Apr 1;35(2):E96-104.

PMID:
22469109
20.

A 12-month phase 3 study of pasireotide in Cushing's disease.

Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM; Pasireotide B2305 Study Group.

N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743. Erratum in: N Engl J Med. 2012 Aug 23;367(8):780.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk